Sheng-Hao Lin
Overview
Explore the profile of Sheng-Hao Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Huang W, Lin S, Hang L, Lin C, Hsu J
J Clin Med
. 2022 Oct;
11(20).
PMID: 36294532
Glycopyrronium (GLY) is a pharmacological maintenance treatment for chronic obstructive pulmonary disease (COPD). However, its effectiveness and tolerability for COPD patients in routine clinical practice have not been well-investigated. This...
12.
Lin C, Li Y, Kor C, Lin S, Ji B, Lin M, et al.
Biomedicines
. 2022 Jun;
10(6).
PMID: 35740474
Method: We conducted a prospective study to recruit adult patients with asthma. Data including age, sex, height, weight, smoking history, medication, emergency visit and admission, pulmonary function testing result, and...
13.
Wu C, Wang C, Chung W, Sheu C, Yang Y, Cheng M, et al.
Thorax
. 2022 Jun;
78(3):225-232.
PMID: 35710744
Background: Adult asthma is phenotypically heterogeneous with unclear aetiology. We aimed to evaluate the potential contribution of environmental exposure and its ensuing response to asthma and its heterogeneity. Methods: Environmental...
14.
Huang T, Huang Y, Hou M, Lu C, Chao T, Chiu T, et al.
Asia Pac J Clin Oncol
. 2022 May;
19(2):e45-e53.
PMID: 35604203
Aim: Buprenorphine is one of the strongest opioids used for the relief of cancer pain. This study aims to evaluate the real-world clinical experiences of transdermal buprenorphine used in moderate...
15.
Huang K, Chen H, Lin C, Wang B, Cheng C, Lin S
Thorac Cancer
. 2022 May;
13(13):1933-1939.
PMID: 35581675
Background: Identifying patients with stage I non-small cell lung cancer (NSCLC) at increased risk of tumor recurrence following surgery remains a major challenge. The current study aimed to compare disease-free...
16.
Cheng W, Wen Y, Chiu Y, Chou C, Lim C, Lin S, et al.
Toxicol In Vitro
. 2022 Mar;
81:105346.
PMID: 35288263
Purpose: Pendulone, an isoflavone compound, is known to act against human cancer cells. However, its role in human non-small cell lung cancer (NSCLC) and the exact molecular mechanisms of action...
17.
Kor C, Li Y, Lin P, Lin S, Wang B, Lin C
J Pers Med
. 2022 Feb;
12(2).
PMID: 35207716
Background: The study developed accurate explainable machine learning (ML) models for predicting first-time acute exacerbation of chronic obstructive pulmonary disease (COPD, AECOPD) at an individual level. Methods: We conducted a...
18.
Lin C, Huang K, Lin C, Wang B, Kor C, Hou M, et al.
Surg Infect (Larchmt)
. 2022 Jan;
23(2):191-198.
PMID: 35085460
Thoracic empyema is a disease with high mortality and morbidity. Video-assisted thoracoscopic surgery (VATS) is recommended to treat advanced stage empyema. The purpose of this study was to explore risk...
19.
Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools
Chen C, Sheu C, Cheng S, Wang H, Lin M, Hsu W, et al.
Int J Chron Obstruct Pulmon Dis
. 2021 Dec;
16:3405-3415.
PMID: 34955636
Background And Aim: Chronic obstructive pulmonary disease (COPD) is frequently underdiagnosed because of the unavailability of spirometers, especially in resource-limited outpatient settings. This study provides real-world evidence to identify optimal...
20.
Chung C, Huang W, Huang H, Chin C, Cheng M, Lee M, et al.
Open Forum Infect Dis
. 2021 Dec;
8(12):ofab565.
PMID: 34901304
Background: Histologic diagnosis of granuloma is often considered clinically equivalent to a definite diagnosis of pulmonary tuberculosis (TB) in endemic areas. Optimal management of surgically resected granulomatous inflammation in lung...